De Sarro G B, Ascioti C, Fersini G, Libri V, Marmo E, Nisticò G
Res Commun Chem Pathol Pharmacol. 1986 Dec;54(3):299-312.
The rats systemic administration of tolonidine in rats (0.05-5.0 mumol/Kg) produced behavioural and electrocortical slow-wave sleep lasting between 35 and 200 min depending on the dose. In addition, a dose-dependent fall in deep body temperature was observed. Similar effects were evoked by infusing tolonidine (5-80 nmol) into the third cerebral ventricle. Behavioural, ECoG and body temperature effects were prevented by previous intraventricular or systemic injection of phentolamine, an antagonist at alpha 1- and alpha 2-adrenoceptors, and of yohimbine, an antagonist at alpha 2-adrenoceptors, whereas prazosin, an alpha 1-adrenoceptor antagonist, was ineffective. In conclusion, the present experiments show that tolonidine possesses central effects similar to those evoked by clonidine and provide further evidence in favour of the idea that central alpha 2-adrenoceptors are involved in the control of slow-wave sleep and body temperature.
给大鼠全身注射托洛尼定(0.05 - 5.0微摩尔/千克),根据剂量不同,可产生持续35至200分钟的行为和皮层脑电图慢波睡眠。此外,还观察到深部体温呈剂量依赖性下降。向第三脑室注入托洛尼定(5 - 80纳摩尔)也会产生类似效果。预先脑室内或全身注射酚妥拉明(一种α1和α2肾上腺素能受体拮抗剂)和育亨宾(一种α2肾上腺素能受体拮抗剂)可阻止行为、脑电图和体温效应,而α1肾上腺素能受体拮抗剂哌唑嗪则无效。总之,本实验表明托洛尼定具有与可乐定相似的中枢效应,并进一步证明中枢α2肾上腺素能受体参与慢波睡眠和体温的调节。